Negative Impact of TET2 Mutations on ...
Document type :
Compte-rendu et recension critique d'ouvrage
Title :
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
Author(s) :
Lassalle, Fanny [Auteur]
Duployez, Nicolas [Auteur]
Vincent, Flavien [Auteur]
Rauch, Antoine [Auteur]
Denimal, Tom [Auteur]
Rosa, Mickael [Auteur]
Labreuche, Julien [Auteur]
Dombrowicz, David [Auteur]
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 [RNMCD]
Staels, Bart [Auteur]
Preudhomme, Claude [Auteur]
Susen, Sophie [Auteur]
van Belle, Eric [Auteur]
Dupont, Annabelle [Auteur]
Duployez, Nicolas [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Vincent, Flavien [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Rauch, Antoine [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Denimal, Tom [Auteur]
Rosa, Mickael [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Labreuche, Julien [Auteur]
Dombrowicz, David [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Récepteurs nucléaires, maladies cardiovasculaires et diabète - U 1011 [RNMCD]
Récepteurs Nucléaires, Maladies Métaboliques et Cardiovasculaires - U1011 [RNMCD]
Staels, Bart [Auteur]
Preudhomme, Claude [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Susen, Sophie [Auteur]
van Belle, Eric [Auteur]
Dupont, Annabelle [Auteur]
![refId](/themes/Mirage2//images/idref.png)
Journal title :
JACC : Basic to Translational Science
Pages :
1424-1435
Publisher :
Elsevier on behalf of the American College of Cardiology Foundation
Publication date :
2023-11
ISSN :
2452-302X
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
HIGHLIGHTS AVS is associated with a high prevalence and large spectrum of CHIP-driver variants. Patients carrying TET2 mutations with low VAF (2%-10%) have a decreased overall 5-year survival after TAVR. These findings ...
Show more >HIGHLIGHTS AVS is associated with a high prevalence and large spectrum of CHIP-driver variants. Patients carrying TET2 mutations with low VAF (2%-10%) have a decreased overall 5-year survival after TAVR. These findings could provide a novel tool for prognosis assessment in patients with severe AVS undergoing TAVR.Show less >
Show more >HIGHLIGHTS AVS is associated with a high prevalence and large spectrum of CHIP-driver variants. Patients carrying TET2 mutations with low VAF (2%-10%) have a decreased overall 5-year survival after TAVR. These findings could provide a novel tool for prognosis assessment in patients with severe AVS undergoing TAVR.Show less >
Language :
Anglais
Popular science :
Non
Source :
Files
- document
- Open access
- Access the document
- main.pdf
- Open access
- Access the document